ONCOCUR is an emerging nanomedicine company with a focus on next generation nanoparticles based precision therapeutics for oncology. We have a portfolio of selective phyto-nano medicine and adjuvants for advanced cancer care.
We cherish to present the age old Ayurvedic practices amalgamated with newer technologies and bring it to society in a contemporary form.
Nanosized drugs have potential to work against multi drug resistance deadly cancers, and offers better therapeutic index by selective targeting, lower drug toxicity, greater intra cellular availability and gene regulation.
Oncocur team endeavours to make life changing next generation nano-therapeutic and nano-adjuvant interventions available to advanced cancer.
Our strength is derived from unique ability of understanding and integrating best of pharmaceutical knowledge and nanodrug design with modern bio-nanotech tools and techniques.
We use our strong expertise in nanoscience, pharma and biotech disciplines to identify and develop innovative and safer therapeutic candidates for advanced cancer care.